PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure

Area of Science:

• Hepatology
• Metabolic pathways
• Drug-induced liver injury

Background:

• Acetaminophen (APAP) is a common painkiller, but overdose causes liver failure.
• Factors like diet and metabolic diseases influence APAP hepatotoxicity.
• The precise molecular mechanisms underlying APAP liver damage are not fully understood.

Purpose of the Study:

• To investigate how a high-fat diet affects APAP-induced liver injury.
• To elucidate the role of peroxisome proliferator-activated receptor gamma coactivator 1-beta (PGC-1β) in APAP hepatotoxicity.

Main Methods:

• Mice were fed a high-fat diet to assess its impact on APAP-induced liver damage.
• Mice with liver-specific PGC-1β overexpression were challenged with a subtoxic APAP dose.
• Evaluated liver lipid accumulation, oxidative stress markers, and outcomes like necrosis and mortality.

Main Results:

• A short-term high-fat diet exacerbated APAP-induced liver damage by increasing liver lipids and activating PGC-1β.
• Hepatic PGC-1β overexpression sensitized the liver to APAP toxicity, even on a standard diet.
• This sensitization was linked to heightened oxidative stress, leading to liver necrosis and death.

Conclusions:

• PGC-1β activation, particularly during high-fat feeding, impairs the liver's ability to handle APAP toxicity.
• Metabolic pathways orchestrated by PGC-1β contribute to fatal outcomes in APAP-induced liver injury.
• Targeting PGC-1β or related pathways may offer strategies to mitigate APAP hepatotoxicity.